Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/02/24
End: 03/31/26
Due: 03/31/27
Phase: N/A
Priority: Normal
Start: 05/31/23
End: 01/09/24
Due: 01/09/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study of WAL0921 in Patients With Glomerular Kidney Diseases | NCT06466135 | Walden Biosciences | user2@example.com | None | 2024-07-02 | 2026-03-31 | 2027-03-31 | - | - | 2025-07-14 |
| Single Ascending Dose Study of WAL0921 in Healthy Subjects | NCT05891366 | Walden Biosciences | user2@example.com | None | 2023-05-31 | 2024-01-09 | 2025-01-09 | - | - | 2025-07-14 |